Stock Events

Stock Events

Aethlon Medical 

€0
0
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

25JunExpected
Q4 2025
Next
-2.32
-2.16
-2.01
-1.85
Expected EPS
-1.8533572056099998
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EJU1.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cytodyn
CYDY
Mkt Cap484.94M
CytoDyn Inc. focuses on innovative treatments for HIV and cancer, similar to Aethlon's focus on life-threatening diseases, making them direct competitors in the biotech space.
Gilead Sciences
GILD
Mkt Cap170.84B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that develops drugs for life-threatening illnesses, including viral diseases, which competes with Aethlon's Hemopurifier therapy.
Sorrento Therapeutics
SRNE
Mkt Cap441,024
Sorrento Therapeutics, Inc. works on developing therapies for cancer, autoimmune, and infectious diseases, directly competing with Aethlon's disease treatment technologies.
Novavax
NVAX
Mkt Cap1.44B
Novavax, Inc. is involved in the development of vaccines for infectious diseases, competing with Aethlon's focus on therapeutic devices for viral diseases.
Moderna
MRNA
Mkt Cap21.3B
Moderna, Inc. specializes in drug discovery and drug development based on messenger RNA, competing in the infectious disease space with Aethlon.
Inovio Pharmaceuticals
INO
Mkt Cap97.09M
Inovio Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of DNA-based immunotherapies, competing with Aethlon's therapeutic technologies.
CRISPR Therapeutics
CRSP
Mkt Cap5.57B
CRISPR Therapeutics AG specializes in gene editing technologies, which could compete with Aethlon's therapeutic approaches in treating diseases at the genetic level.
Novartis
NVS
Mkt Cap293.34B
Novartis AG is a global healthcare company that researches, develops, manufactures, and markets healthcare products, competing across a broad range of therapeutic areas including those targeted by Aethlon.

About

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
Show more...
CEO
Mr. James B. Frakes M.B.A.
Employees
14
Country
United States
ISIN
US00808Y6041

Listings

MU
DE
EJU1.MU
STU
DE
EJU1.STU
F
DE
EJU1.F
LSE
GB
0A6R.LSE

0 Comments

Share your thoughts

FAQ

What is Aethlon Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aethlon Medical stocks are traded under the ticker EJU1.STU.
When is the next Aethlon Medical earnings date?▼
Aethlon Medical is going to release the next earnings report on June 25, 2026.
What were Aethlon Medical earnings last quarter?▼
EJU1.STU earnings for the last quarter are -2.06 EUR per share, whereas the estimation was -2.32 EUR resulting in a +10.91% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Aethlon Medical have?▼
As of April 24, 2026, the company has 14 employees.
In which sector is Aethlon Medical located?▼
Aethlon Medical operates in the Health & Wellness sector.
When did Aethlon Medical complete a stock split?▼
Aethlon Medical has not had any recent stock splits.
Where is Aethlon Medical headquartered?▼
Aethlon Medical is headquartered in San Diego, United States.